Development and validation of a LC/MS/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 860, Issue 2, 2007, Pages 153-159

  Paglia, G ^a   D'Apolito, O ^a   Garofalo, D ^a   Scarano, C ^b   Corso, G ^a,b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b OORR   (Italy)

Author keywords

10 Hydroxycarbazepine; LC MS MS; Oxcarbazepine; Therapeutic drug monitoring

Indexed keywords

10-HYDROXYCARBAZEPINE; OXCARBAZEPINE; THERAPEUTIC DRUG MONITORING;

CHEMICAL ANALYSIS; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATIENT TREATMENT; ULTRAVIOLET RADIATION;

METABOLITES;

CYHEPTAMIDE; DIOL CARBAZEPINE; DRUG METABOLITE; LICARBAZEPINE; OXCARBAZEPINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; ULTRAVIOLET RADIATION; VALIDATION STUDY;

ANTICONVULSANTS; CALIBRATION; CARBAMAZEPINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TANDEM MASS SPECTROMETRY;

EID: 36549090414     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.10.025     Document Type: Article

References (22)

1. Glauser T.A. Pharmacotherapy 21 (2001) 904
2. Park B.K., Coleman J.W., and Kitteringham N.R. Biochem. Pharmacol. 36 (1987) 581
3. Flesh G. Clin. Drug Invest. 24 (2004) 185
4. Grant S.M., and Fauld D. Drugs 43 (1992) 873
5. Faigle J.W., and Menge G.P. Behav. Neurol. 3 (1990) 21
6. Benetello Jr. P., Furlanut M., Baraldo M., Tonon A., and Furlanut M. Eur. Neurol. 48 (2002) 200
7. Dam M., and Ostergaard L.H. Antiepileptic Drugs. fourth ed. vol. 987 (1995), Raven press, New York
8. Friis M.L., Kristensen O., Boas J., et al. Acta Neurol. Scand. 87 (1993) 224
9. Tecoma E.S. Epilepsia 40S5 (1999) 37
10. Breton H., Cociglio M., Bressolle F., Peyriere H., Blayac J.P., and Buys D.H. J. Chromatogr. B 828 (2005) 80
11. Kłys M., Rojek S., and Bolechała F. J. Chromatogr. B 825 (2005) 38
12. Maurer H.H., Kratzsch C., Weber A.A., Peters F.T., and Kraemer T. J. Mass Spectrom. 37 (2002) 687
13. Mandrioli R., Ghedini N., Albani F., Kenndler E., and Raggi M.A. J. Chromatogr. B 783 (2003) 253
14. Franceschi L., and Furlanut M. Pharmacol. Res. 51 (2005) 297
15. Souppart C., Decherf M., Humbert H., and Maurer G. J. Chromatogr. B 762 (2001) 9
16. Contin M., Balboni M., Callegati E., Candela C., Albani F., Riva R., and Baruzzi A. J. Chromatogr. B 828 (2005) 113
17. Kushnir M.M., Rockwood A.L., Nelson G.J., Yu B., and Urry F.M. Clin. Biochem. 38 (2005) 319
18. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 75 (2003) 3019
19. Lanckmans K., Clinckers R., Van Eeckhaut A., Sarre S., Smolders I., and Michotte Y. J. Chromatogr. B 831 (2006) 205
20. Lanckmans K., Van Eeckhaut A., Sarre S., Smolders I., and Michotte Y. J. Chromatogr. A 1131 (2006) 166
21. de Sousa Maia M.B., do Nascimento D.F., Martins I.L., Cunha A.N., de Lima F.E., Bezerra F.A., de Moraes M.O., and de Moraes M.E. J. Pharmaceut. Biomed. Anal. 45 (2007) 304
22. Corso G., D'Apolito O., and Paglia G. Rapid Commun. Mass Spectrom. 21 (2007) 269